tiprankstipranks
Trending News
More News >
Silexion Therapeutics (SLXN)
NASDAQ:SLXN
US Market
Advertisement

Silexion Therapeutics (SLXN) Financial Statements

Compare
205 Followers

Silexion Therapeutics Financial Overview

Silexion Therapeutics's market cap is currently $8.45M. The company's EPS TTM is $-19.982; its P/E ratio is ―; Silexion Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22
Currency in USD

Silexion Therapeutics Earnings and Revenue History

Silexion Therapeutics Debt to Assets

Silexion Therapeutics Cash Flow

Silexion Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis